New answer by Medical Oncologist at IHA Hem Onc Consult (February 14, 2023)
Agree with clinical trials, Pirtobrutinib, or cellular therapy. If these options are not possible, a combination of BTKi and Venetoclax can be considered. A recent paper (belo...